ReShape Lifesciences Inc Stock News

The Bariatric Surgery Devices Market research report focuses on consolidations and acquisitions, extensions, examination of central participants, the foundation date of organization regions served, fabricating base, and income of vital participants. Moreover, the report also studies breakdown by product and

During the last session, ReShape Lifesciences Inc. (NASDAQ:RSLS)s traded shares were 1.16 million, with the beta value of the company hitting -1.09. At the end of the trading day, the stocks price was $2.09, reflecting an intraday gain of 5.03% or $0.1. The 52-week high for the RSLS share is $32.31, that puts it down After A 3.47% Jump In The Last Week, Does ReShape Lifesciences Inc. (NASDAQ: RSLS) Still Make Sense To Buy? Read More »

5 penny stocks to watch this week The post Best Penny Stocks To Buy? 5 To Watch With Potential Catalysts This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

The stock price of ReShape Lifesciences Inc (NASDAQ: RSLS) increased by over 19% pre-market today. This is why it happened.

SAN CLEMENTE, Calif., Dec. 9, 2021 /PRNewswire/ -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that Bart

State Street Corp purchased a new position in ReShape Lifesciences Inc. (OTCMKTS:RSLS) in the second quarter, HoldingsChannel reports. The fund purchased 109,999 shares of the medical device companys stock, valued at approximately $550,000. Other hedge funds also recently added to or reduced their stakes in the company. Alpine Global Management LLC bought a new position []

ReShape Lifesciences Inc. (NASDAQ:RSLS) concluded the trading at $1.69 on Friday, December 03 with a fall of -5.06% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.78 and 5Y monthly beta was reading 1.70 with its price kept floating in the Analysts Release Price Targets And Ratings For ReShape Lifesciences Inc. (RSLS) Read More »

Himax Technologies, Inc. (HIMX) with the stream of 0.81% also noticed, India ReShape Lifesciences Inc. (RSLS) encountered a rapid change of -1.98% in the last hour of Mondays trading session. The post Traders cant mares this Stock: Himax Technologies, Inc. (NASDAQ:HIMX), ReShape Lifesciences Inc. (NASDAQ:RSLS) appeared first on Stocks Equity .

Vanguard Group Inc. purchased a new position in ReShape Lifesciences Inc. (OTCMKTS:RSLS) during the second quarter, Holdings Channel reports. The fund purchased 51,120 shares of the medical device companys stock, valued at approximately $256,000. A number of equities research analysts recently issued reports on the company. Alliance Global Partners restated a buy rating and issued []

ReShape Lifesciences Inc. (NASDAQ:RSLS) price on Friday, November 19, fall -0.99% below its previous days close as a downside momentum from buyers pushed the stocks value to $2.01. A look at the stocks price movement, the close in the last trading session was $2.03, moving within a range at $1.95 and $2.05. The beta value ReShape Lifesciences Inc. (RSLS): An Important Analyst Insights Read More »

ReShape Lifesciences Inc. (OTCMKTS:RSLS) CFO Thomas Stankovich sold 4,320 shares of the companys stock in a transaction dated Tuesday, November 2nd. The stock was sold at an average price of $2.69, for a total value of $11,620.80. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Thomas []

National advertising campaign and Virtual Media Tour achieve all key performance indicators SAN CLEMENTE, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, previously announced successful campaigns to help more consumers take control of their lives and their weight with a national direct-to-consumer television The post ReShape Lifesciences Witnesses Great Success with Direct-to-Consumer Marketing Campaign appeared first on ForexTV .

In the latest trading session, 1.09 million ReShape Lifesciences Inc. (NASDAQ:RSLS) shares changed hands as the companys beta touched -1.16. With the companys most recent per share price at $2.18 changed hands at -$0.19 or -8.02% at last look, the market valuation stands at $39.39M. RSLSs current price is a discount, trading about -1382.11% off The Stock Of ReShape Lifesciences Inc. (NASDAQ: RSLS) Was Forecast By Analysts To Close At $10.25 Per Share By 2021. Read More »

Maxim Group reissued their buy rating on shares of ReShape Lifesciences (OTCMKTS:RSLS) in a research note issued to investors on Friday morning, TipRanks reports. They currently have a $8.00 price objective on the medical device companys stock. Separately, Alliance Global Partners reiterated a buy rating and issued a $10.25 target price (down from $13.75) on []

ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q3 2021 Results - Earnings Call Transcript